Vincent Richard G

Chief Financial OfficerOncternal Therapeutics, Inc. (ONCT) · full profile →Form 4 · filed Oct 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 2, 2023Disposed to issuer(D)110K0
Oct 2, 2023Disposed to issuer(D)29K0
Oct 2, 2023Disposed to issuer(D)210K0
Oct 2, 2023Grant(A)75K75K
Oct 2, 2023Grant(A)35K35K
Oct 2, 2023Grant(A)280K280K
Oct 2, 2023Grant(A)110K110K
Oct 2, 2023Disposed to issuer(D)280K0
Oct 2, 2023Grant(A)29K29K
Oct 2, 2023Grant(A)210K210K
Oct 2, 2023Disposed to issuer(D)75K0
Oct 2, 2023Disposed to issuer(D)35K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-052015) within minutes of acceptance. Every field above traces to the original document. Verify it directly: